This trial is sponsored by Sobi and ADC Therapeutics

Symposium
  • 18th ICML •
  • 17 June, 2025 •
  • •

Treatment sequencing in R/R DLBCL: Dissecting the emerging challenge from bench to bedside

Andrew Davies , Romano Danesi, Gloria Lacoboni , Marek Trněný

Available materials

Slides Video
Symposium
  • EHA •
  • 14 June, 2025 •
  • •

Dissecting Treatment Sequencing in Relapsed/Refractory Diffuse Large B-cell Lymphoma​ From Laboratory to Real Life

Pier Luigi Zinzani, Romano Danesi, Joel Wight, Marek Trněný

Available materials

Slides Video
Publication
  • EHA •
  • 14 June, 2025 •
  • •

Updated Safety Run-In Results From LOTIS-5: A Phase 3, Randomized Trial of Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Patients With R/R DLBCL/HGBL

Carmelo Carlo-Stella , Michal Kwiatek , Julien Depaus, Sebastian Grosicki, Sylvia Snauwaert, Edwin Kingsley, Javier López-Jiménez, Blanca Sanchez-Gonzalez, Andrzej Urban, Andrew Niewiarowski, Neus Domper-Rubio, Luqiang Wang, Eva Tiecke, Marie Toukam, Mehdi Hamadani

Available materials

Poster
Publication
  • EHA •
  • 14 June, 2025 •
  • •

Initial Results from LOTIS-7: A Phase 1b Study of Loncastuximab Tesirine Plus Glofitamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Juan Pablo Alderuccio, Craig Okada, Gilles Crochet, Emily C. Ayers, Marie Hu, Silvia Ferrari, Paolo Caimi, Mehdi Hamadani, Julien Depaus, Enrico Derenzini, Jose Sandoval-Sus, Ruben Reyes, Andrzej Urban, Erica Rave, Eva Tiecke, Marie Toukam, Pier Luigi Zinzani

Available materials

Poster
Publication
  • ASCPT •
  • 29 May, 2025 •
  • •

QSP Modeling of Loncastuximab Tesirine-lpyl Combined with T Cell–Dependent Bispecific Antibodies Bridges Knowledge and Dose Regimen Strategy

Yuezhe Li, A. Katharina Wilkins, Jimena Davis, Tim Knab, Marie Toukam, Marie Toukam, Marie Toukam, Joseph P. Boni, Daniel C. Kirouac

Available materials

Poster
Sign up for alerts